ADPIC
The New Standard of Global Pharma
Abu Dhabi PPP Initiative building a smart, sustainable, and fully integrated pharmaceutical ecosystem — a strategic partnership between sovereign enterprise and global innovation.
To deliver an integrated pharmaceutical industrial city covering the full value chain — from generics and natural therapeutics to advanced molecular R&D and sustainable manufacturing.
- 50 km² industrial pharmaceutical footprint
- Generic formulations at mass scale
- Ayurvedic and natural therapeutics
- Advanced R&D and biotech
- Sustainable, net-zero manufacturing
- Phased $1–15B sovereign investment
- PPP structuring and execution
Mass-scale production of essential medicines focused on regional health security and cost optimization.
Integrating ancient wisdom with modern clinical standards to deliver proven herbal and natural solutions.
Pioneering molecular biology and biotechnology breakthroughs through sovereign-backed innovation hubs.
Net-zero manufacturing infrastructure across a 50 km² integrated pharmaceutical industrial footprint.
End-to-end pharmaceutical logistics, packaging, and distribution serving regional and global markets.
Sovereign Public-Private Partnership anchoring the ecosystem with long-term government backing and regulatory alignment.
Technology transfer, licensing, and joint ventures with leading international pharmaceutical and biotech innovators.
Phased $1–15B investment program co-structured with sovereign funds and institutional capital partners.
Collaboration with universities and research centers to seed advanced R&D pipelines and clinical capability.
Interested in working with ADPIC? Send us an inquiry and we will get back to you.
ADPIC — The New Standard of Global Pharma